Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-9,524
Closed -$1.74M 395
2021
Q3
$1.74M Buy
9,524
+2,352
+33% +$489K 0.04% 276
2021
Q2
$1.94M Buy
7,172
+5,000
+230% +$1.31M 0.04% 251
2021
Q1
$575K Buy
+2,172
New +$613K 0.01% 290

Other funds holding AMED

PFS Investments's AMED Position: Q4 2021 in Review

PFS Investments sold out of Amedisys (AMED) in Q4 2021, closing a stake of 9,524 shares — an estimated $1.74M sold.

PFS Investments first reported a position in AMED in Q1 2021 and held it in 3 quarters. The position peaked at $1.94M in Q2 2021. 324 funds tracked by Wall St. Rank hold AMED as of Q4 2021.

  • PFS Investments reported no remaining Amedisys position as of Q4 2021 after selling out during the quarter.
  • PFS Investments sold 9,524 Amedisys shares in Q4 2021, an estimated $1.74M.
  • PFS Investments first reported a position in Amedisys in Q1 2021 and held it in 3 quarters.
  • PFS Investments's Amedisys position peaked at $1.94M in Q2 2021.
  • 324 funds tracked by Wall St. Rank held Amedisys as of Q4 2021.

Based on PFS Investments's 13F filing for Q4 2021, filed 11 Feb 2022.